LOVELAND, Colo., April 11, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced its 2019 Annual Meeting of Stockholders. The meeting is scheduled for 9 a.m. MT/11 a.m. ET on Thursday, May 2, 2019 and will be held at Heska corporate headquarters located at 3760 Rocky Mountain Avenue, Loveland, CO. Stockholders of record as of March 13, 2019, are entitled to notice of, and to attend and vote at, the annual meeting.
2019 Annual Meeting of Stockholders
Thursday, May 2, 2019
9 a.m. MT/11 a.m. ET
Heska Corporation Headquarters
Stockholders unable to attend may access the Annual Meeting via live webcast or telephone.
To access the webcast:
To access via telephone:
From within the United States, please dial 1-855-327-6837
From outside of the United States, please dial 1-631-891-4304
Reference Conference ID: 10006534
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 85% of revenue, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment, which represents approximately 15% of revenue. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.
SOURCE Heska Corporation